Immuneering (IMRX) Assets Average (2021 - 2026)
Immuneering's Assets Average history spans 6 years, with the latest figure at $223.4 million for Q1 2026.
- On a quarterly basis, Assets Average rose 332.12% to $223.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $223.4 million, a 332.12% increase, with the full-year FY2025 number at $142.3 million, up 83.32% from a year prior.
- Assets Average came in at $223.4 million for Q1 2026, down from $236.5 million in the prior quarter.
- The five-year high for Assets Average was $236.5 million in Q4 2025, with the low at $45.4 million in Q2 2025.
- Historically, Assets Average has averaged $120.0 million across 5 years, with a median of $116.3 million in 2023.
- Biggest five-year swings in Assets Average: crashed 45.74% in 2025 and later skyrocketed 332.12% in 2026.
- Year by year, Assets Average stood at $128.0 million in 2022, then dropped by 15.46% to $108.2 million in 2023, then tumbled by 43.98% to $60.6 million in 2024, then soared by 290.07% to $236.5 million in 2025, then dropped by 5.55% to $223.4 million in 2026.
- Business Quant data shows Assets Average for IMRX at $223.4 million in Q1 2026, $236.5 million in Q4 2025, and $140.6 million in Q3 2025.